Sanofi logo

Sanofi(NASDAQ) SNY

Market Cap$94.17BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2002)+154%
5 Year+1%
1 Year-18%
1 Month-11%
Premium Feature
Moneyball Superscore
78/100
$39.53
-0.98%
-0.39Today
Pre market$40.20+$0.67 (+1.70%)
Sanofi last closing stock price
MetricPriceDate
Last closeUSD 39.512026-10-05
Sanofi stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-4.06%USD 41.182026-09-28
1 month-10.69%USD 44.242026-09-04
3 month-8.07%USD 42.982026-07-07
Year to date-13.95%USD 45.922025-12-31
1 year-18.08%USD 48.232025-10-03
3 year-15.81%USD 46.932023-10-06
5 year+1.3%USD 39.002021-10-06
Since inception+153.56%USD 15.582002-07-01

Sanofi Financials at a Glance

Market Cap

$94.17BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€48.92B

Net Income (TTM)

€3.96B

EPS (TTM)

$1.94

P/E Ratio

20.26

Dividend

$2.42

Beta (Volatility)

0.33 (Low)

Price

$39.53

Volume

109,449.896

Open

$39.83

Previous Close

$39.51

Daily Range

$39.18 - $39.88

52-Week Range

$39.18 - $52.68

Estimated Earnings Date

N/A

SNY News

GettyImages-1411285056 (1)

Sanofi Boasts a Dividend Yield of 5.4%, Trades Below 9x Earnings, and Just Got an FDA Win. Are Income Investors Missing a Rare Opportunity?

Matthew BenjaminAug 26, 2026
Getty - happy rich with cash money sitting

The Smartest Dividend Stock to Buy With $1,000 Right Now (Spoiler: It Yields 5.6%.)

Selena MaranjianJul 28, 2026
Investor pointing at a chart.

Bargain Hunters: These 3 High-Yielding Stocks Recently Hit New 52-Week Lows

David Jagielski, CPAJun 30, 2026
A team of scientists reviewing results in a lab.

1 Dirt Cheap Growth Stock to Buy Right Now

David Jagielski, CPAMay 18, 2026
bundle bills rolled and kept together with a rubber band sit on a table

What Is Price Elasticity of Demand?

Lee SamahaOct 13, 2025
GettyImages-1263079549.jpg

What Is Elasticity in Finance?

Motley Fool StaffApr 17, 2025
Child receiving a vaccination shot from a healthcare professional

Why Sanofi Stock Flew Higher on Friday

Eric VolkmanOct 25, 2024
Patient and physician smiling during a visit

Why Sanofi Stock Was Robustly Healthy Today

Eric VolkmanSep 3, 2024
Page 1

SNY: Motley Fool Moneyball Superscore

78

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sanofi

Sanofi operates as a leading global pharmaceutical enterprise, dedicated to the research, development, production, and distribution of a wide array of therapeutic solutions across the United States, Europe, and numerous international markets. The company strategically organizes its operations into three core divisions: Pharmaceuticals, Vaccines, and Consumer Healthcare.

Products and Services
  • Specialized therapies for complex conditions, including oncology and rare diseases
  • Extensive vaccine portfolio for pediatric and adult immunizations
  • Over-the-counter products for wellness, pain management, and personal care
Growth Outlook
  • Strong pipeline with numerous products in various research stages
  • Collaboration with GlaxoSmithKline on a recombinant Covid-19 vaccine
  • Strategic partnerships enhancing innovation in immunology and inflammation
Financial Highlights
  • Q2 2026 revenue of €12.3 billion, reflecting robust demand
  • Net income of €343 million in Q2 2026, showcasing profitability
  • TTM dividend yield of 11.11%, indicating strong shareholder returns
Sanofi's diverse product offerings and strategic partnerships position the company well for future growth. The recent quarterly performance highlights a solid revenue stream and profitability, which may attract potential investors. The company's commitment to innovation and collaboration in the pharmaceutical sector further enhances its market presence. With a strong focus on research and development, Sanofi is poised to continue delivering value to its stakeholders.
AI Generated • Sep 17, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

76,493

CEO

Paul Hudson

Website

www.sanofi.com

Headquarters

Paris, IF 75017, FR

SNY Financials

Key Financial Metrics (TTM)

Gross Margin

72.77%

Operating Margin

20.58%

Net Income Margin

8.09%

Return on Equity

5.52%

Return on Capital

10.47%

Return on Assets

3.07%

Earnings Yield

4.94%

Dividend Yield

6.12%

Payout Ratio

1.24%

Stock Overview

Market Cap

$94.17BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

2.38B

Volume

109.45K

Avg. Volume

2.91M

Financials (TTM)

Gross Profit

€35.72B

Operating Income

€7.24B

EBITDA

€12.41B

Operating Cash Flow

€14.29B

Capital Expenditure

-€2.52B

Free Cash Flow

€11.77B

Cash & ST Invst.

€6.35B

Total Debt

€23.58B

Sanofi Performance Analysis

Sanofi annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 45,188,742,6911.2%
20232023-12-31EUR 40,884,548,758-9.5%
20242024-12-31EUR 44,436,937,9608.7%
20252025-12-31EUR 49,235,341,67210.8%
Sanofi sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3022.7%
Q42025-12-31-7.3%
Q12026-03-31-7.9%
Q22026-06-309.4%
Sanofi annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 3.5019.7%
20232023-12-31EUR 2.32-33.6%
20242024-12-31EUR 2.393.0%
20252025-12-31EUR 2.400.1%
Sanofi sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-28.8%
Q42025-12-31-229.1%
Q12026-03-31145.7%
Q22026-06-30-79.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€12.30B

+14.6%

Gross Profit

€9.28B

+19.9%

Gross Margin

75.47%

N/A

Market Cap

$94.17BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.23M

N/A

Employees

76,493

N/A

Net Income

€343.00M

-91.3%

EBITDA

€1.68B

-11.3%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€6.35B

-58.7%

Total Debt

€23.58B

+5.8%

Accounts Receivable

€9.21B

+12.2%

Inventory

€24.12B

+150.8%

Long Term Debt

€16.32B

+10.9%

Short Term Debt

€7.25B

-4.1%

Return on Assets

3.07%

N/A

Return on Invested Capital

10.37%

N/A

Free Cash Flow

€3.90B

N/A

Operating Cash Flow

€5.42B

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,777.74+0.01%
^DJIDJI
$51,304.21+0.00%
^IXICNASDAQ
$27,461.27+0.01%
BTCBitcoin
$85,510.00+0.00%

Questions About SNY

What is the current price of Sanofi?

Sanofi is trading at $39.51 per share.

What is the 52-week range for Sanofi?

Over the past 52 weeks, Sanofi has traded between $39.18 and $52.68.

How much debt does Sanofi have?

As of the most recent reporting period, Sanofi reported total debt of €23.88B.

How much cash does Sanofi have on hand?

Sanofi reported €8.68B in cash and cash equivalents in its most recent financial results.

What is Sanofi’s dividend yield?

Sanofi currently has a dividend yield of 6.12%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services